TLDR Biotech

TLDR Biotech
Archive
Page -18

The Latest Biotech & Pharma Updates

Biotech & Pharma Updates | July 28 - 29, 2025

🧬 FDA's big CBER shake-up, Novo Nordisk dives while AstraZeneca soars, and massive cuts coming to Merck & Co. ($3B by EOY 2027)

Anis Fahandej-Sadi

Jul 29, 2025

Biotech & Pharma Updates | July 27 - 28, 2025

🧬 MapLight's $372.5M Series D, Adaptimmune sells-out (commercial assets)

Anis Fahandej-Sadi

Jul 28, 2025

Biotech & Pharma Updates | July 25 - 27, 2025

🧬 Hengrui & GSK link-up on 12 medicines, while Roche still in it for the gene therapy long-game

Anis Fahandej-Sadi

Jul 25, 2025

Biotech & Pharma Updates | July 23 - 24, 2025

🧬 3-peat of CGT layoffs, Eli Lilly goes in on molecular gates (up to $856M), and FDA (likely) wants new safety studies for Sarepta's Elevidys

Anis Fahandej-Sadi

Jul 24, 2025

Biotech & Pharma Updates | July 22 - 23, 2025

🧬 Dispatch Bio's $200M+ launch against solid tumors, FDA opens up 1-2 month priority review pathway, and Sarepta-partner Arrowhead still confident on state of $550M licensing deal

Anis Fahandej-Sadi

Jul 23, 2025

Biotech & Pharma Updates | July 21 - 22, 2025

🧬 Sanofi's $1.6B vaccine acquisition, while Replimmune's viral immunotherapy for melanoma lands an FDA rejection.

Anis Fahandej-Sadi

Jul 22, 2025

Biotech & Pharma Updates | July 20 - 21, 2025

🧬 Sarepta continues dominating headlines, while AstraZeneca and Biogen commit billions to US domestic manufacturing

Anis Fahandej-Sadi

Jul 21, 2025

Biotech & Pharma Updates | July 18 - 20, 2025

🧬 Sarepta Therapeutics to square off with the FDA on Elevidys gene therapy, while Moderna cancelled mRNA factory in Japan

Anis Fahandej-Sadi

Jun 18, 2025

Lowering CAR-T Costs: Paths to more affordable cell therapies

A long form piece by yours truly - originally published on Signals

Anis Fahandej-Sadi

May 16, 2025

Time for a Pause

Some hard truths about TLDR Biotech

Anis Fahandej-Sadi

May 07, 2025

Biotech & Pharma Updates | May 5 - 6, 2025

Bristol Myers Squibb pledges $40B for US R&D and manufacturing, NewLimit $130M Series B with ambitions to develop epigenetic drugs to extend healthy lifespan using AI and genomics, Trump orders FDA to streamline drug factory regulations and reduce building timeframes from 5-10 years + 34 more stories

Anis Fahandej-Sadi

May 06, 2025

Biotech & Pharma Updates | May 4 - 5, 2025

European Commission pledges €500M ($568M) in research funding to attract scientists amid US funding cuts, Deerfield Management raises $600M Healthcare Innovations Fund to invest in therapeutics and AI, Novo Nordisk's oral Wegovy (semaglutide) formulation awaits FDA approval decision by Q4, Bristol Myers Squibb cutting 516 more jobs in New Jersey + 31 more stories

Anis Fahandej-Sadi

First Back

1 2 3 4 5 6 7 8

Next Last